Researchers have started to recruit patients to a new pioneering trial that will use combination therapy to reduce fibrosis in patients with head and neck cancer (HNC).
A phase II trial starting at UCLH is to offer patients with an aggressive type of brain cancer immunotherapy on the NHS for the first time.
The BRC Patient & Public Involvement (PPI) & Communications team is looking for a Communications Officer to join the team.
Taking an anti-inflammatory pill could help make vaccines more effective for elderly people, a new UCL study has found.
i-sense, a research collaboration supported by our BRC, has developed a promising new approach to detect immunity to Ebola virus.